INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 458m ago
HOUSE PTR58m ago
SEC 13F58m ago
ROBINHOOD CHAIN57m ago
Corporate insider
HK

Humphreys Keith

DirectorCIK 0002014900

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells1 / 0
Max Insider Score33
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
HK
Humphreys KeithDirector
INDVIndivior Pharmaceuticals, Inc.
Grant or award
A—
6,518 sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Indivior Pharmaceuticals, Inc.Director · Jan 7, 2026
17
HK
Humphreys KeithDirector
INDVIndivior Pharmaceuticals, Inc.
Grant or award
A
—
3,722 sh
Jan 26, 2026
Jan 28, 2026
traded Jan 26, 2026
+2d
SEC FORM 4

Evidence

33
HK
Humphreys KeithDirector
INDVIndivior Pharmaceuticals, Inc.
Open-market purchase · 10b5-1 plan
BUY$27K
775 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence